Documentos de Académico
Documentos de Profesional
Documentos de Cultura
Vancomycin
It is indicated for the treatment of serious, life-threatening
infections by Gram-positive bacteria which are unresponsive to
other less toxic antibiotics.
Rifampicin
Rifampicin is another type of antibiotics that is used to kill
the bacterium caused by MRSA.
Bacterium
Are small organisms (but not as small as viruses) that causes
illness to animals and human.
MRSA can get everyone but the most of the people are over 80+.
But if the treatment not works and the most of the bacteria dies
and. They become resistant then they are immune against
antibiotics. This Immune reaction comes to a position if the
antibiotics are used over.
This diagram shows you how antibiotics work successfully against
bacteria and how antibiotic doesn’t work so well against the
bacteria. In the first picture antibiotics are earlier than the
bacterium so they aren’t immune against the antibiotics but in the
second picture the antibiotics are too late so the bacterium
survives under a cover and are immune against the antibiotics. So
the bacterium is immune against this bacterium forever. Some
microorganisms are equipped with genes that give them resistance
against these antibiotics. This resistance can take the form of the
split have the antibiotic molecule or the rejection of the cell.... so
the Organisms with these genes can transfer them to other bacteria
and thereby immunize them as well. Each year over 94,000 people
are infected with 19,000 deaths, more than the rate of caused by
HIV. There was a very rapid increase from 2% to 64%. The MRSA
transfer from human to animal, like horse, and it is of concern. The
Transmission between animals and humans has also been raised.
Other areas that lead to MRSA and may need surgical interventions
are joint infections. Even with antibiotic therapy patients are dying
because of week immune system.
Social issues
44% of population discharged from hospitals are attacked by MRSA
and it become a very big public issue among the social community.
Economic issues
MRSA requires new treatments and more researches which leads
also to economical issues. Then the new treatments will cost more
and it is expensive. It takes a lot of money and time to develop new
drugs , then the doctors start to prescribe rarely working
antibiotics, which makes drug companies less enthusiastic about
the developing the new medications. (It needs £3000000 to develop
an effective infection control practices in hospital.)
Conclusion:
MRSA is a pressing, global health problem, because the antibiotics
used becomes resistant.
We see too that in Portugal the disease MRSA is spread over 50 %.)
More scientists are working on alternative methods:
1. Light Therapy
2. A new type of antibiotics
1. Light Therapy
1375 words
COURSE
WORK
MRSA
BIOLOGY
MR.SHEEHAN
BY
ARULKUMARAN
LOGANATHAN